FDA — authorised 23 August 2018
- Marketing authorisation holder: DYAX CORP
- Status: approved
🇺🇸 Takhzyro in United States
FDA authorised Takhzyro on 23 August 2018
Marketing authorisation
Takhzyro in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in United States
Frequently asked questions
Is Takhzyro approved in United States?
Yes. FDA authorised it on 23 August 2018.
Who is the marketing authorisation holder for Takhzyro in United States?
DYAX CORP holds the US marketing authorisation.